SARS-CoV-2 antibodies in inflammatory neurological conditions: a multicentre retrospective comparative study
Open Access
- 12 May 2023
- journal article
- research article
- Published by Springer Science and Business Media LLC in Immunologic Research
- Vol. 71 (5), 717-724
- https://doi.org/10.1007/s12026-023-09384-2
Abstract
It is well established that neurological and non-neurological autoimmune disorders can be triggered by viral infections. It remains unclear whether SARS-CoV-2 infection induces similar conditions and whether they show a distinctive phenotype. We retrospectively identified patients with acute inflammatory CNS conditions referred to our laboratory for antibody testing during the pandemic (March 1 to August 31, 2020). We screened SARS-COV-2 IgA/IgG in all sera by ELISA and confirmed the positivity with additional assays. Clinical and paraclinical data of SARS-COV-2-IgG seropositive patients were compared to those of seronegative cases matched for clinical phenotype, geographical zone, and timeframe. SARS-CoV-2-IgG positivity was detected in 16/339 (4%) sera, with paired CSF positivity in 3/16. 5 of these patients had atypical demyelinating disorders and 11 autoimmune encephalitis syndromes. 9/16 patients had a previous history of SARS-CoV-2 infection and 6 of them were symptomatic. In comparison with 32 consecutive seronegative controls, SARS-CoV-2-IgG-positive patients were older, frequently presented with encephalopathy, had lower rates of CSF pleocytosis and other neurological autoantibodies, and were less likely to receive immunotherapy. When SARS-CoV-2 seropositive versus seronegative cases with demyelinating disorders were compared no differences were seen. Whereas seropositive encephalitis patients less commonly showed increased CSF cells and protein, our data suggest that an antecedent symptomatic or asymptomatic SARS-CoV-2 infection can be detected in patients with autoimmune neurological conditions. These cases are rare, usually do not have specific neuroglial antibodies.Keywords
Funding Information
- Università degli Studi di Verona
This publication has 17 references indexed in Scilit:
- Neurological updates: neurological complications of CAR-T therapyZeitschrift für Neurologie, 2020
- Anti–SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcomeNeurology Neuroimmunology & Neuroinflammation, 2020
- Clinical Presentation and Outcomes of Severe Acute Respiratory Syndrome Coronavirus 2–Related Encephalitis: The ENCOVID Multicenter StudyThe Journal of Infectious Diseases, 2020
- Acute disseminated encephalomyelitis after SARS-CoV-2 infectionNeurology Neuroimmunology & Neuroinflammation, 2020
- Neurological associations of COVID-19The Lancet Neurology, 2020
- A new coronavirus associated with human respiratory disease in ChinaNature, 2020
- COVID-19-Induced Acute Bilateral Optic NeuritisJournal of Investigative Medicine High Impact Case Reports, 2020
- Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter studyZeitschrift für Neurologie, 2017
- A clinical approach to diagnosis of autoimmune encephalitisThe Lancet Neurology, 2016
- Case Definitions, Diagnostic Algorithms, and Priorities in Encephalitis: Consensus Statement of the International Encephalitis ConsortiumClinical Infectious Diseases, 2013